CLINICAL_TRIALS
trial_result
· 2006-07-25
Clinical Trial Update: Duloxetine in the Treatment of Melancholic Depression [Phase 3]
Summary
A Phase 3 trial evaluating duloxetine for major depressive disorder with melancholic features has completed, sponsored by Eli Lilly and Company.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED